Surveillance for hepatocellular carcinoma: Just do it!

American Journal of Gastroenterology

Volumn 108, Issue 6, 2013, Pages 1013-1014

  Giannini, Edoardo G ^a   Trevisani, Franco ^b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

CANCER EPIDEMIOLOGY; CANCER STAGING; HEALTH CARE COST; HEPATITIS C; HUMAN; LETTER; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; METASTASIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR INVASION;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE;

EID: 84878918978     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2013.98     Document Type: Letter

References (5)

1. Singal AG, Nehra M, Adams-Huet B et al. Detection of hepatocellular carcinoma at advanced stages among patients in the HALT-C trial: where did surveillance fail? Am J Gastroenterol 2013 ; 108 : 425-32.
2. Santi V, Trevisani F, Gramenzi A et al. Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. J Hepatol 2010 ; 53 : 291-7.
3. Lee JM, Trevisani F, Vilgrain V et al. Imaging diagnosis and staging of hepatocellular carcinoma. Liver Transpl 2011 ; 17 (Suppl 2) : S34-43.
4. Giannini EG, Erroi V, Trevisani F. Eff ectiveness of ?-fetoprotein for hepatocellular carcinoma surveillance: the return of the living-dead? Expert Rev Gastroenterol Hepatol 2012 ; 6 : 441-4.
5. Andersson KL, Salomon JA, Goldie SJ et al. Cost eff ectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2008 ; 6 : 1418-24.